Trustworthy AI: Closing the gap between development and integration of AI systems in ophthalmic practice
Year: 2021
Type: review
Abstract: An increasing number of artificial intelligence (AI) systems are being proposed in ophthalmology, motivated by the variety and amount of clinical and imaging data, as well as their potential benefits at the different stages of patient care. Despite achieving close or even superior performance to that of experts, there is a critical gap between development and integration of AI systems in ophthalmic practice. This work focuses on the importance of trustworthy AI to close that gap. We identify the main aspects or challenges that need to be considered along the AI design pipeline so as to generate systems that meet the requirements to be deemed trustworthy, including those concerning accuracy, resiliency, reliability, safety, and accountability. We elaborate on mechanisms and considerations to address those aspects or challenges, and define the roles and responsibilities of the different stakeholders involved in AI for ophthalmic care, i.e., AI developers, reading centers, healthcare providers, healthcare institutions, ophthalmological societies and working groups or committees, patients, regulatory bodies, and payers. Generating trustworthy AI is not a responsibility of a sole stakeholder. There is an impending necessity for a collaborative approach where the different stakeholders are represented along the AI design pipeline, from the definition of the intended use to post-market surveillance after regulatory approval. This work contributes to establish such multi-stakeholder interaction and the main action points to be taken so that the potential benefits of AI reach real-world ophthalmic settings.
Institutions: Radboud University Medical Center, University of Amsterdam, Erasmus MC, Institute of Molecular and Clinical Ophthalmology Basel, University of Washington, Amsterdam UMC Location University of Amsterdam, Fondation Asile des Aveugles, Amsterdam University Medical Centers, University of Lausanne, Moorfields Eye Hospital NHS Foundation Trust, University College London
Language: English
Subfield: Health Informatics
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $5,000
Funders: European Federation of Pharmaceutical Industries and Associations, European Commission, Universiteit van Amsterdam, Carl Zeiss Meditec AG, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Innovative Medicines Initiative, Moorfields Eye Hospital NHS Foundation Trust, National Institutes of Health, Erasmus Universitair Medisch Centrum Rotterdam, National Institute on Aging, National Eye Institute
Awards: Epidemiology and clinical outcomes of diabetic macular edema, G434337789, G4417598090, G602260107, Develop and validate appropriate and acceptable outcome measures in intermediate age-related macular degeneration for future interventional clinical trials - Sofia ref.: 116076, G8153097362, Adult Changes in Thought (ACT) Research Program, Aging eyes and aging brains in studying alzheimer''s disease: Modern ophthalmic data collection in the adult changes in thought (ACT) study
OpenAlex ID: W4200295368
